What Are the Determinants of Explicit and Implicit Motor Imagery Ability in Stroke Patients?

Healthy Clinical Trial

Official title:

What Are the Determinants of Explicit and Implicit Motor Imagery Ability in Stroke Patients?: A Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03635502
• Other study ID #: IstanbulMU1
• Status: Completed
• Start date: August 17, 2018
• Est. completion date: September 30, 2018

Study information

• Verified date: December 2019
• Source: Istanbul Medeniyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Motor imagery (MI) might be described as a dynamic process in which an individual mentally stimulates an action without any overt movement. After stroke, motor imagery ability is impaired and also due to structure of MI, not every stroke patients is able to perform MI. Therefore, the aim of the study is a) to compare both explicit and implicit motor imagery ability (MIA) between patients with stroke and healthy subjects, b) to examine predictive effects of clinical characteristics for MIA after stroke.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 77
• Est. completion date: September 30, 2018
• Est. primary completion date: September 30, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Being between the ages of 18-80,

• Having a unilateral stroke for the first time and 0-6 months since stroke onset

• 24 points and above in Mini Mental State Examination (MMDM)

• Not having a disease that may interfere with the study such as cardiac diseases, orthopedic conditions,etc.

Exclusion Criteria:

• Multiple strokes

• Sever cognitive dysfunction (<24 points in MMDM)

• Unilateral neglect

• Upper extremity pain that interferes with the study or aggravated with movement

• Visual problems, aphasia or another sequel that might limit the assessment

Related Conditions & MeSH terms

• Healthy
• Stroke

Locations

Country	Name	City	State
Turkey	Bakirköy Dr. Sadi Konuk Training and Research Hospital	Istanbul

Sponsors (3)

Lead Sponsor	Collaborator
Istanbul Medeniyet University	Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Movement Imagery Questionnaire-3 (MIQ-3)	MIQ-3 evaluates an individual's motor imagery ability in 3 subscales: 1. internal imagery, 2. external imagery, 3. kinesthetic imagery. Each of these scales ranges from 1 to 7 where 1 indicates very hard to see/feel (image) and 7 indicates very easy to see/feel. 12 items are included in the MIQ-3 and every item is scored according to the scales. The higher the score in subscales, the better the results are.	15 min
Primary	Chaotic Motor Imagery Assessment- Hand Rotation	Hand Rotation is the first component of Chaotic Motor Imagery Assessment. In this measure, 96 drawings of each hand (left and right) from 4 different plane and at 12 different angle are presented to the individuals and then, it is asked to decide whether it is left or right hand. Total test time, total accuracy, total wrong answers, right accuracy, left accuracy, impaired hand and non-impaired hand accuracy is recorded as outcome scores.	20 min
Primary	Box and Block Test	Box and Block Test is used to calculate mental chronometry (MC) ratio. During the test, patients are asked to carry 15 blocks first physically and then mentally from one box to another. As outcome scores, the time required to carry 15 blocks physically (MET) and mentally (MIT) are recorded. Then MC ratio is calculated with the formula: (MET-MIT)/ MET.	5 min
Primary	Fugl-Meyer Assessment- Upper Extremity	Upper extremity part of Fugl Meyer Assessment (FMAUE) is used to evaluate patients' motor impairment level. Total motor and sensory scores are recorded. Then, patients are divided into 4 different categories according to their motor impairment level: 23-31 points: poor upper extremity function,; 32-47 points: limited function,; 48-52 points: notable function, 4.53-66 points: full function.	10 min
Secondary	Motor Activity Log-28	Turkish version of MAL-28 was used to assess how much (amount of use scale) and how well (how well scale) the patients used their upper extremity in daily life after stroke. These 2 different scales are calculated separately with range of 0-5 points.The higher the points are, the better the patients' situation.	5 min